Our Research

Funded Research

The GI Motility Disorders Unit at Western Sydney University is focused on creating medical technologies to address unmet clinical needs through working with patients, local health district, and industry partners. Their vision is to develop a screening technology for the early detection of oesophageal cancer, as a pre-metastatic diagnosis more than doubles a patient’s survival (46%) compared to the current rate of 19%.    

 

With support from OCAGI, they are able to bring together talented researchers from the diverse fields of chemical engineering, robotics, clinical research, and gastroenterology to accelerate the development of their medical devices. Together we want to create innovative technologies that translates to patient-benefits. 

​​Call us:

(02) 9829 3999

Mark Grundy Oesophageal Cancer Awareness Group Incorporated
ABN 90 352 600 244 is registered with the Australian Taxation office as a Deductible Gift Recipient. All donations over $2 are tax deductible.

 

Privacy Policy and Disclaimer

 

This information is not intended to replace actual medical knowledge and advice. Always consult your doctor/specialist if you have any concerns.